Current Problems in Cardiology
Volume 32, Issue 8 , Pages 419-494 , August 2007

Pregnancy: Maternal and Fetal Heart Disease

References 

  1. Otterson WN, Dunnihoo DR. In:  Pauerstein CJ editors. Cardiac disease. New York: John Wiley & Sons; 2005;p. 627–644
  2. Ueland K, Metcalfe J. Circulatory changes in pregnancy. Clin Obstet Gynecol. 1975;18(3):41–50
  3. Chesley LC. Cardiovascular changes in pregnancy. Obstet Gynecol Annu. 1975;4:71–97
  4. Longo LD. Maternal blood volume and cardiac output during pregnancy: a hypothesis of endocrinologic control. Am J Physiol. 1983;245(5 Pt 1):R720–R729
  5. Preedy JR, Aitken EH. The effect of estrogen on water and electrolyte metabolism (I. The normal). J Clin Invest. 1956;35(4):423–429
  6. Ferris TF, Gorden P, Mulrow PJ. Rabbit uterus as a source of renin. Am J Physiol. 1967;212(3):698–702
  7. Prowse CM, Gaensler EA. Respiratory and acid-base changes during pregnancy. Anesthesiology. 1965;26:381–392
  8. Pernoll ML, Metcalfe J, Schlenker TL, et al. Oxygen consumption at rest and during exercise in pregnancy. Respir Physiol. 1975;25(3):285–293
  9. Kjeldsen J. Hemodynamic investigations during labour and delivery. Acta Obstet Gynecol Scand Suppl. 1979;89:1–252
  10. Mabie WC, DiSessa TG, Crocker LG, et al. A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol. 1994;170(3):849–856
  11. Kerr MG. The mechanical effects of the gravid uterus in late pregnancy. J Obstet Gynaecol Br Commonw. 1965;72:513–529
  12. Holmes F. The supine hypotensive syndrome (1960). Anaesthesia. 1995;50(11):972–977
  13. Kinsella SM, Lohmann G. Supine hypotensive syndrome. Obstet Gynecol. 1994;83(5 Pt 1):774–788
  14. Hurst JW, Staton J, Hubbard D. Precordial murmurs during pregnancy and lactation. N Engl J Med. 1958;259(11):515–517
  15. O’Rourke RA, Ewy GA, Marcus FI, et al. Cardiac auscultation in pregnancy. Med Ann Dist Columbia. 1970;39(2):92–94
  16. Robson SC, Hunter S, Boys RJ, et al. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1989;256(4 Pt 2):H1060–H1065
  17. Campos O. Doppler echocardiography during pregnancy: physiological and abnormal findings. Echocardiography. 1996;13(2):135–146
  18. Campos O, Andrade JL, Bocanegra J, et al. Physiologic multivalvular regurgitation during pregnancy: a longitudinal Doppler echocardiographic study. Int J Cardiol. 1993;40(3):265–272
  19. Robson SC, Dunlop W, Boys RJ, et al. Cardiac output during labour. Br Med J (Clin Res Ed). 1987;295(6607):1169–1172
  20. Ueland K, Hansen JM. Maternal cardiovascular dynamics. 3 (Labor and delivery under local and caudal analgesia). Am J Obstet Gynecol. 1969;103(1):8–18
  21. Henricks CH, Quilligan EJ. Cardiac output during labor. Am J Obstet Gynecol. 1956;71:953–972
  22. Bonow RO, Carabello B, de Leon AC, et al. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease (Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease)). J Heart Valve Dis. 1998;7(6):672–707
  23. Siu SC, Sermer M, Harrison DA, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation. 1997;96(9):2789–2794
  24. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515–521
  25. Szekely P, Turner R, Snaith L. Pregnancy and the changing pattern of rheumatic heart disease. Br Heart J. 1973;35(12):1293–1303
  26. Hameed A, Karaalp IS, Tummala PP, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol. 2001;37(3):893–899
  27. Desai DK, Adanlawo M, Naidoo DP, et al. Mitral stenosis in pregnancy: a four-year experience at King Edward VIII Hospital, Durban, South Africa. BJOG. 2000;107(8):953–958
  28. Demir I, Yilmaz H, Basarici I, et al. [Prognostic factors of mitral stenosis during pregnancy]. Anadolu Kardiyol Derg. 2002;2(3):213–217
  29. Colman JM, Sermer M, Seaward PG, et al. Congenital heart disease in pregnancy. Cardiol Rev. 2000;8(3):166–173
  30. Lao TT, Adelman AG, Sermer M, et al. Balloon valvuloplasty for congenital aortic stenosis in pregnancy. Br J Obstet Gynaecol. 1993;100(12):1141–1142
  31. Myerson SG, Mitchell AR, Ormerod OJ, et al. What is the role of balloon dilatation for severe aortic stenosis during pregnancy?. J Heart Valve Dis. 2005;14(2):147–150
  32. Lao TT, Adelman AG, Sermer M, et al. Balloon valvuloplasty for congenital aortic stenosis in pregnancy. Br J Obstet Gynaecol. 1993;100(12):1141–1142
  33. Mooij PN, de Jong PA, Bavinck JH, et al. Aortic valve replacement in the second trimester of pregnancy: a case report. Eur J Obstet Gynecol Reprod Biol. 1988;29(4):347–352
  34. Nelson DM, Main E, Crafford W, et al. Peripartum heart failure due to primary pulmonary hypertension. Obstet Gynecol. 1983;62(suppl 3):58s–63s
  35. Penning S, Robinson KD, Major CA, et al. A comparison of echocardiography and pulmonary artery catheterization for evaluation of pulmonary artery pressures in pregnant patients with suspected pulmonary hypertension. Am J Obstet Gynecol. 2001;184(7):1568–1570
  36. Easterling TR, Ralph DD, Schmucker BC. Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilators. Obstet Gynecol. 1999;93(4):494–498
  37. Shime J, Mocarski EJ, Hastings D, et al. Congenital heart disease in pregnancy: short- and long-term implications. Am J Obstet Gynecol. 1987;156(2):313–322
  38. Presbitero P, Somerville J, Stone S, et al. Pregnancy in cyanotic congenital heart disease (Outcome of mother and fetus). Circulation. 1994;89(6):2673–2676
  39. Saidi AS, Bezold LI, Altman CA, et al. Outcome of pregnancy following intervention for coarctation of the aorta. Am J Cardiol. 1998;82(6):786–788
  40. Beauchesne LM, Connolly HM, Ammash NM, et al. Coarctation of the aorta: outcome of pregnancy. J Am Coll Cardiol. 2001;38(6):1728–1733
  41. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J. 1958;46(5099):755–762
  42. Weiss BM, Zemp L, Seifert B, et al. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998;31(7):1650–1657
  43. Lacassie HJ, Germain AM, Valdes G, et al. Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstet Gynecol. 2004;103(5 Pt 2):1118–1120
  44. Geohas C, McLaughlin VV. Successful management of pregnancy in a patient with Eisenmenger syndrome with epoprostenol. Chest. 2003;124(3):1170–1173
  45. Goodwin TM, Gherman RB, Hameed A, et al. Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy. Am J Obstet Gynecol. 1999;180(1 Pt 1):64–67
  46. Breen TW, Janzen JA. Pulmonary hypertension and cardiomyopathy: anaesthetic management for caesarean section. Can J Anaesth. 1991;38(7):895–899
  47. Beauchesne LM, Warnes CA, Connolly HM, et al. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol. 2005;45(4):595–598
  48. Veldtman GR, Connolly HM, Grogan M, et al. Outcomes of pregnancy in women with tetralogy of Fallot. J Am Coll Cardiol. 2004;44(1):174–180
  49. Lind J, Wallenburg HC. The Marfan syndrome and pregnancy: a retrospective study in a Dutch population. Eur J Obstet Gynecol Reprod Biol. 2001;98(1):28–35
  50. Rossiter JP, Repke JT, Morales AJ, et al. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol. 1995;173(5):1599–1606
  51. Sakaguchi M, Kitahara H, Watanabe T, et al. Successful surgical treatment for acute aortic dissection in pregnancy with Marfan’s syndrome. Jpn J Thorac Cardiovasc Surg. 2005;53(4):220–222
  52. Autore C, Conte MR, Piccininno M, et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40(10):1864–1869
  53. Shotan A, Ostrzega E, Mehra A, et al. Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol. 1997;79(8):1061–1064
  54. Gowda RM, Khan IA, Mehta NJ, et al. Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. Int J Cardiol. 2003;88(2-3):129–133
  55. Page RL, Hamdan MH, Joglar JA. Arrhythmias occurring during pregnancy. Card Electrophysiol Rev. 2002;6(1-2):136–139
  56. Tan HL, Lie KI. Treatment of tachyarrhythmias during pregnancy and lactation. Eur Heart J. 2001;22(6):458–464
  57. Brown CE, Wendel GD. Cardiac arrhythmias during pregnancy. Clin Obstet Gynecol. 1989;32(1):89–102
  58. Page RL. Treatment of arrhythmias during pregnancy. Am Heart J. 1995;130(4):871–876
  59. Rashba EJ, Zareba W, Moss AJ, et al. LQTS Investigators Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. Circulation. 1998;97(5):451–456(10)
  60. O’Hare MF, Murnaghan GA, Russell CJ, et al. Sotalol as a hypotensive agent in pregnancy. Br J Obstet Gynaecol. 1980;87(9):814–820
  61. Magee LA, Downar E, Sermer M, et al. Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol. 1995;172(4 Pt 1):1307–1311
  62. Bartalena L, Bogazzi F, Braverman LE, et al. Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest. 2001;24(2):116–130
  63. Luppi CJ. Cardiopulmonary resuscitation: pregnant women are different. AACN Clin Issues. 1997;8(4):574–585
  64. Lampert MB, Lang RM. Peripartum cardiomyopathy. Am Heart J. 1995;130(4):860–870
  65. Cunningham FG, Pritchard JA, Hankins GD, et al. Peripartum heart failure: idiopathic cardiomyopathy or compounding cardiovascular events?. Obstet Gynecol. 1986;67(2):157–168
  66. Demakis JG, Rahimtoola SH. Peripartum cardiomyopathy. Circulation. 1971;44(5):964–968
  67. Lampert MB, Lang RM. Peripartum cardiomyopathy. Am Heart J. 1995;130(4):860–870
  68. Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111(16):2050–2055
  69. Elkayam U, Tummala PP, Rao K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med. 2001;344(21):1567–1571
  70. Chapa JB, Heiberger HB, Weinert L, et al. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol. 2005;105(6):1303–1308
  71. Rahimtoola SH, Tak T. The use of digitalis in heart failure. Curr Probl Cardiol. 1996;21(12):781–853
  72. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure (Results of a Veterans Administration Cooperative Study). N Engl J Med. 1986;314(24):1547–1552
  73. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary (A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America). Circulation. 2001;104(24):2996–3007
  74. Demakis JG, Rahimtoola SH, Sutton GC, et al. Natural course of peripartum cardiomyopathy. Circulation. 1971;44(6):1053–1061
  75. Felker GM, Jaeger CJ, Klodas E, et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J. 2000;140(5):785–791
  76. Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. Ann Intern Med. 1996;125(9):751–762
  77. Ladner HE, Danielsen B, Gilbert WM. Acute myocardial infarction in pregnancy and the puerperium: a population-based study. Obstet Gynecol. 2005;105(3):480–484
  78. Iadanza A, Del PA, Barbati R, et al. Acute ST elevation myocardial infarction in pregnancy due to coronary vasospasm: a case report and review of literature. Int J Cardiol. 2006;115(1):81–85
  79. James AH, Jamison MG, Biswas MS, et al. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation. 2006;113(12):1564–1571
  80. Shade GH, Ross G, Bever FN, et al. Troponin I in the diagnosis of acute myocardial infarction in pregnancy, labor, and post partum. Am J Obstet Gynecol. 2002;187(6):1719–1720
  81. Ascarelli MH, Grider AR, Hsu HW. Acute myocardial infarction during pregnancy managed with immediate percutaneous transluminal coronary angioplasty. Obstet Gynecol. 1996;88(4 Pt 2):655–657
  82. Fleyfel M, Bourzoufi K, Huin G, et al. Recombinant tissue type plasminogen activator treatment of thrombosed mitral valve prosthesis during pregnancy. Can J Anaesth. 1997;44(7):735–738
  83. Usta IM, Abdallah M, El Hajj M, et al. Massive subchorionic hematomas following thrombolytic therapy in pregnancy. Obstet Gynecol. 2004;103(5 Pt 2):1079–1082
  84. Webber MD, Halligan RE, Schumacher JA. Acute infarction, intracoronary thrombolysis, and primary PTCA in pregnancy. Cathet Cardiovasc Diagn. 1997;42(1):38–43
  85. Togni M, Amann FW, Follath F. Spontaneous multivessel coronary artery dissection in a pregnant woman treated successfully with stent implantation. Am J Med. 1999;107(4):407–408
  86. Parry AJ, Westaby S. Cardiopulmonary bypass during pregnancy. Ann Thorac Surg. 1996;61(6):1865–1869
  87. Bernal JM, Miralles PJ. Cardiac surgery with cardiopulmonary bypass during pregnancy. Obstet Gynecol Surv. 1986;41(1):1–6
  88. Strickland RA, Oliver WC, Chantigian RC, et al. Anesthesia, cardiopulmonary bypass, and the pregnant patient. Mayo Clin Proc. 1991;66(4):411–429
  89. Pomini F, Mercogliano D, Cavalletti C, et al. Cardiopulmonary bypass in pregnancy. Ann Thorac Surg. 1996;61(1):259–268
  90. Mahli A, Izdes S, Coskun D. Cardiac operations during pregnancy: review of factors influencing fetal outcome. Ann Thorac Surg. 2000;69(5):1622–1626
  91. North RA, Sadler L, Stewart AW, et al. Long-term survival and valve-related complications in young women with cardiac valve replacements. Circulation. 1999;99(20):2669–2676
  92. Jamieson WR, Miller DC, Akins CW, et al. Pregnancy and bioprostheses: influence on structural valve deterioration. Ann Thorac Surg. 1995;60(suppl 2):S282–S286
  93. Salazar E, Espinola N, Roman L, et al. Effect of pregnancy on the duration of bovine pericardial bioprostheses. Am Heart J. 1999;137(4 Pt 1):714–720
  94. Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 1980;68(1):122–140
  95. Vitale N, De Feo M, De Santo LS, et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol. 1999;33(6):1637–1641
  96. Hirsh J, Fuster V, Ansell J, et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol. 2003;41(9):1633–1652
  97. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J. 1994;71(2):196–201
  98. Iturbe-Alessio I, Fonseca MC, Mutchinik O, et al. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med. 1986;315(22):1390–1393(27)
  99. Hanania G. Management of anticoagulants during pregnancy. Heart. 2001;86(2):125–126
  100. Pitkin RM, Perloff JK, Koos BJ, et al. Pregnancy and congenital heart disease. Ann Intern Med. 1990;112(6):445–454
  101. Canobbio MM, Mair DD, van der Velde , et al. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol. 1996;28(3):763–767
  102. Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Pregnancy and delivery in women after Fontan palliation. Heart. 2006;92(9):1290–1294
  103. Gerardin B, Houyel L, Discazeaux B, et al. [Successful pregnancy after Fontan procedure complicated by recurrent junctional tachycardia]. Arch Mal Coeur Vaiss. 1993;86(6):935–938
  104. Ito M, Takagi N, Sugimoto S, et al. Pregnancy after undergoing the Fontan procedure for a double outlet right ventricle: report of a case. Surg Today. 2002;32(1):63–65
  105. Singh H, Bolton PJ, Oakley CM. Pregnancy after surgical correction of tetralogy of Fallot. Br Med J (Clin Res Ed). 1982;285(6336):168–170
  106. Clarkson PM, Wilson NJ, Neutze JM, et al. Outcome of pregnancy after the Mustard operation for transposition of the great arteries with intact ventricular septum. J Am Coll Cardiol. 1994;24(1):190–193
  107. Lowenstein BR, Vain NW, Perrone SV, et al. Successful pregnancy and vaginal delivery after heart transplantation. Am J Obstet Gynecol. 1988;158(3 Pt 1):589–590
  108. Miller LW, Labovitz AJ, McBride LA, et al. Echocardiography-guided endomyocardial biopsy (A 5-year experience). Circulation. 1988;78(5 Pt 2):III99–III102
  109. Scott JR, Wagoner LE, Olsen SL, et al. Pregnancy in heart transplant recipients: management and outcome. Obstet Gynecol. 1993;82(3):324–327
  110. Baxi LV, Rho RB. Pregnancy after cardiac transplantation. Am J Obstet Gynecol. 1993;169(1):33–34(July)
  111. Laifer SA, Yeagley CJ, Armitage JM. Pregnancy after cardiac transplantation. Am J Perinatol. 1994;11(3):217–219
  112. Alper MH, Roaf ER. Anesthetic management of the high-risk pregnancy. Clin Obstet Gynecol. 1973;16(1):347–360
  113. Bonica JJ. Obstetric analgesia and anesthesia (Recent trends and advances). NY State J Med. 1970;70(16):2079–2084(15)
  114. Malinow AM, Ostheimer GW. Anesthesia for the high-risk parturient. Obstet Gynecol. 1987;69(6):951–964
  115. Mitterschiffthaler G. Regional anesthesia for the pregnant cardiac patient. Acta Anaesthesiol Scand Suppl. 1996;109:180–184
  116. Copel JA, Harrison D, Whittemore R, et al. Intrathecal morphine analgesia for vaginal delivery in a woman with a single ventricle (A case report). J Reprod Med. 1986;31(4):274–276
  117. Schabel JE, Jasiewicz RC. Anesthetic management of a pregnant patient with congenitally corrected transposition of the great arteries for labor and vaginal delivery. J Clin Anesth. 2001;13(7):517–520
  118. Mitani GM, Steinberg I, Lien EJ, et al. The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation. Clin Pharmacokinet. 1987;12(4):253–291
  119. Rotmensch HH, Rotmensch S, Elkayam U. Management of cardiac arrhythmias during pregnancy (Current concepts). Drugs. 1987;33(6):623–633
  120. Chan V, Tse TF, Wong V. Transfer of digoxin across the placenta and into breast milk. Br J Obstet Gynaecol. 1978;85(8):605–609
  121. Pruyn SC, Phelan JP, Buchanan GC. Long-term propranolol therapy in pregnancy: maternal and fetal outcome. Am J Obstet Gynecol. 1979;135(4):485–489
  122. Barden TP, Stander RW. Effects of adrenergic blocking agents and catecholamines in human pregnancy. Am J Obstet Gynecol. 1968;102(2):226–235
  123. Wadworth AN, Murdoch D, Brogden RN. Atenolol (A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders). Drugs. 1991;42(3):468–510
  124. Mason BA, Ricci-Goodman J, Koos BJ. Adenosine in the treatment of maternal paroxysmal supraventricular tachycardia. Obstet Gynecol. 1992;80:478–480
  125. Ferencz C, Rubin JD, Mc Carter RJ, et al. Congenital heart disease: prevalence at live birth (The Baltimore-Washington Infant Study). Am J Epidemiol. 1985;121:31–36
  126. Chervenak FA, McCullough LB. Perinatal ethics: a practical method of analysis of obligations to mother and fetus. Obstet Gynecol. 1985;66:442–446
  127. American Academy of Pediatrics Committee on Bioethics. Fetal therapy: ethical considerations. Pediatrics. 1988;81:898–899
  128. Copel JA, Pilu G, Kleinman CS. Congenital heart disease and extracardiac anomalies: associations and indications for fetal echocardiography. Am J Obstet Gynecol. 1986;154:1121–1132
  129. Copel JA, Pilu G, Kleinman CS. Extracardiac anomalies and congenital heart disease. Sem Perinatol. 1993;17:89–105
  130. DeVore GR. Trisomy 21: 91% detection rate using second-trimestser ultrasound markers. Ultrasound Obstet Gynecol. 2000;16:133–141
  131. Buyon JP, Clancey R, Di Donato F, et al. Cardiac 5-HT serotoninergic receptors, 52KD SSA/Ro and autoimmune-associated congenital heart block. J Autoimmun. 2002;19:79–86
  132. Schmidt LG, Ulmer HE, Silverman NH, et al. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol. 1991;91:1360–1366
  133. Cooley WC, Graham JM. Down syndrome—an update and review for the primary pediatrician. Clin Pediatr. 1991;30:233–253
  134. Botto LD, May K, Fernhoff PM, et al. A population-based study of the 22ql1.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics. 2003;112:101–107
  135. Cuneo BF, Strasburger JF. Management strategy for fetal tachycardia. Obstet Gynecol. 2000;96:575–581
  136. Sklansky M, Greenberg M, Lucas V, et al. Intrapericardial teratoma in a twin fetus: diagnosis and management. Obstet Gynecol. 1997;89:807–809
  137. Tworetzky W, Wilkins-Haug L, Jennings RW, et al. Balloon dilation of severe aortic stenosis in the fetus. Circulation. 2004;11:2125-1
  138. Reddy VM, Liddicoat JR, Klein JR, et al. Long-term fetal outcome after fetal cardiac bypass: fetal survival to full term and organ abnormalities. J Thorac Cardiovasc Surg. 1996;111:536–544
  139. Rychik J, Tian Z, Cohen MS, et al. Acute cardiovascular effects of fetal surgery in the human. Circulation. 2004;110:1549–1556
  140. Harrison MR. Fetal surgery. Am J Obstet Gynecol. 1996;174:1255–1264
  141. Kovalchin JP, Silverman NH. The impact of fetal echocardiography. Pediatr Cardiol. 2004;25:299–306
  142. Bonnet D, Coltri A, Butera G, et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation. 1999;99:916–918
  143. Chang AC, Huhta JC, Yoon GY, et al. Diagnosis, transport, and outcome in fetuses with left ventricular outflow tract obstruction. J Thorac Cardiovasc Surg. 1991;102:841–848
  144. Franklin O, Burch M, Manning N, et al. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart. 2002;87:67–69
  145. Verheijen PM, Lisowski LA, Stoutenbeek P, et al. Prenatal diagnosis of congenital heart disease affects preoperative acidosis in the newborn infant. J Thorac Cardiovasc Surg. 2001;121:798–803
  146. Kumar RK, Newburger JW, Gauvreau K, et al. Comparison of outcome when hypoplastic left heart syndrome and transposition of the great arteries are diagnosed prenatally versus when diagnosis of these two conditions is made only postnatally. Am J Cardiol. 1999;83:1649–1653
  147. Montana E, Khoury MJ, Cragan JD, et al. Trends and outcomes after prenatal diagnosis of congenital cardiac malformations by fetal echocardiography in a well defined birth population, Atlanta, Georgia, 1990-1994. J Am Coll Cardiol. 1996;28:1805–1809
  148. Sklansky M, Tang A, Levy D, et al. Maternal psychological impact of fetal echocardiography. J Am Soc Echocardiogr. 2002;15:159–166
  149. Carmichael S, Shaw G. Maternal life event stress and congenital anomalies. Epidemiology. 2000;11:30–35
  150. Hansen D, Lou H, Olsen J. Serious life events and congenital malformations: a national study with complete follow-up. Lancet. 2000;356:875–880
  151. Allan LD, Cook A, Sullivan I, et al. Hypoplastic left heart syndrome: effects of fetal echocardiography on birth prevalence. Lancet. 1991;337:959–961
  152. Daubeney PE, Sharland GK, Cook AC, et al. Pulmonary atresia with intact ventricular septum: impact of fetal echocardiography on incidence at birth and postnatal outcome (UK and Eire Collaborative Study of Pulmonary Atresia with Intact Ventricular Septum). Circulation. 1998;98:562–566
  153. Bull Catherine for the British Paediatric Cardiac Association. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. Lancet. 1999;354:1242–1247
  154. Small M, Copel JA. Indications for fetal echocardiography. Pediatr Cardiol. 2004;25:210–222
  155. Buskens E, Grobbee DE, Frohn-Mulder IM, et al. Efficacy of routine fetal ultrasound screening for congenital heart disease in normal pregnancy. Circulation. 1996;94:67–72
  156. LeFevre ML, Bain RP, Ewigman BG, et al. RADIUS (Routine Antenatal Diagnostic Imaging with Ultrasound) Study Group A randomized trial of prenatal ultrasonographic screening: impact on maternal management and outcome. Am J Obstet Gynecol. 1993;169:483–489
  157. Tegnander E, Eik-Nes SH, Johansen OJ, et al. Prenatal dectection of heart defects at the routine fetal examination at 18 weeks in a non-selected population. Ultrasound Obstet Gynecol. 1995;5:373–380
  158. Allan LD, Chita SK, Sharland GK, et al. The accuracy of fetal echocardiography in the diagnosis of congenital heart disease. Int J Cardiol. 1989;25:279–288
  159. Davis GK, Farquhar CM, Allan LD, et al. Structural cardiac abnormalities in the fetus: reliability of prenatal diagnosis and outcome. Br J Obstet Gynecol. 1990;97:27–31
  160. Meyer-Wittkopf M, Cooper S, Sholler G. Correlation between fetal cardiac diagnosis by obstetric and pediatric cardiologist sonographers and comparison with postnatal findings. Ultrasound Obstet Gynecol. 2001;17:392–397
  161. Stumfplen I, Stumfplen A, Wimmer M, et al. Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease. Lancet. 1996;348:854–857
  162. Hyett JA, Moscosco G, Papanagiotou G, et al. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol. 1996;7:245–250
  163. Hyett J, Perdu M, Sharland G, et al. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ. 1999;318:81–85
  164. Allan LD, Crawford DC, Chita SK, et al. Familial recurrence of congenital heart disease in a prospective series of mothers referred for fetal echocardiography. Am J Cardiol. 1986;58:334–337
  165. Boughman JA, Berg KA, Astemborski JA, et al. Familial risks of congenital heart defect in a population-based epidemiological study. Am J Med Genet. 1987;26:839–849
  166. Nora JJ, Nora AH. Maternal transmission of congenital heart diseases: new recurrence risk figures and the questions of cytoplasmic inheritance and vulnerability to teratogens. Am J Cardiol. 1987;59:459–463
  167. Rowland TW, Hubbell JP, Nadas AS. Congenital heart disease in infants of diabetic mothers. J Pediatr. 1973;83:815–820
  168. Miller E, Hare JW, Cloherty JP, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med. 1981;302:1331–1334
  169. Becerra JE, Khoury MJ, Cordero JF, et al. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case control study. Pediatrics. 1990;85:1–9
  170. Zierler S. Maternal drugs and congenital heart disease. Obstet Gynecol. 1985;65:155–165
  171. Zierler S, Rothman KJ. Congenital heart disease in relation to maternal use of Bendictin and other drugs in early pregnancy. N Engl J Med. 1985;313:347–352
  172. Burn J, Brennan P, Little J, et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet. 1998;351:311–316
  173. Gill HK, Splitt M, Sharland GK, et al. Patterns of recurrence of congenital heart disease (An analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography). J Am Coll Cardiol. 2003;42:923–929
  174. Ott WJ. The accuracy of antenatal fetal echocardiography screening in high- and low-risk patients. Am J Obstet Gynecol. 1995;172:1741–1749
  175. Ewigman BG, Crane JP, Frigoletto FD, et al. Effect of prenatal ultrasound screening on perinatal outcome. N Engl J Med. 1993;329:821–827
  176. Copel JA, Pilu G, Green J, et al. Fetal echocardiographic screening for congenital heart disease: the importance of the four chamber view. Am J Obstet Gynecol. 1987;157:648-5
  177. Vergani P, Mariani S, Ghidini A, et al. Screening for congenital heart disease with the four-chamber view of the fetal heart. Am J Obstet Gynecol. 1992;167:1000–1003
  178. Achiron R, Glaser J, Gelernter I, et al. Extended fetal echocardiographic examination for detecting cardiac malformations in low risk pregnancies. BMJ. 1992;304:671–674
  179. Kirk JS, Riggs TW, Comstock CH, et al. Prenatal screening for cardiac anomalies: the value of routine addition of the aortic root to the four-chamber view. Obstet Gynecol. 1994;84:427–431
  180. Bromley B, Estroff JA, Sanders SP, et al. Fetal echocardiography: accuracy and limitations in a population at high and low risk for heart defects. Am J Obstet Gynecol. 1992;166:1473–1481
  181. Haak MC, Twisk JW, Van Vugt JM. How successful is fetal echocardiographic examination in the first trimester of pregnancy?. Ultrasound Obstet Gynecol. 2002;20:9–13
  182. Huggon IC, Ghi T, Cook AC, et al. Fetal cardiac abnormalities identified prior to 14 weeks gestation. Ultrasound Obstet Gynecol. 2002;20:22–27
  183. Allan LD, Santos R, Pexieder T. Anatomical and echocardiographic correlates of normal cardiac morphology in the late first trimester fetus. Heart. 1997;77:68–72
  184. Carvalho JS, Moscoso G, Tekay A, et al. Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies. Heart. 2004;90:921–926
  185. Haak M, Van Vugt JMG. Echocardiography in early pregnancy (Review of literature). J Ultrasound Med. 2003;22:271–280
  186. Danford DA, Cronican P. Hypoplastic left heart syndrome: progression of left ventricular dilation and dysfunction to left ventricular hypoplasia in utero. Am Heart J. 1992;123:1712–1713
  187. Trines J, Hornberger LK. Evolution of heart disease in utero. Pediatr Cardiol. 2004;25:287–298
  188. Hornberger LK, Sanders SP, Rein AJ, et al. Left heart obstructive lesions and left ventricular growth in the midtrimester fetus (A longitudinal study). Circulation. 1995;92:1531–1538
  189. Hornberger LK, Sanders SP, Sahn DJ, et al. In utero pulmonary artery and aortic growth and potential for progression of pulmonary outflow tract obstruction in tetralogy of Fallot. J Am Coll Cardiol. 1995;25:739–749
  190. DeVore GR, Donnerstein RL, Kleinman CS, et al. Fetal echocardiography (I. Normal anatomy as determined by real-time-directed M-mode ultrasound). Am J Obstet Gynecol. 1982;144:249–260
  191. Allan LD, Tynan MJ, Campbell S, et al. Echocardiographic and anatomical correlates in the fetus. Br Heart J. 1980;44:444–451
  192. Sahn DJ, Lange LW, Allen HD, et al. Quantitative real-time cross-sectional echocardiography in the developing normal human fetus and newborn. Circulation. 1980;62:588–597
  193. Allan L. Technique of fetal echocardiography. Pediatr Cardiol. 2004;25:223–233
  194. Allan L. The normal fetal heart. In:  Allan L,  Hornberger L,  Sharland G editor. Textbook of fetal cardiology. London, England: Greenwich Medical Media; 2000;p. 55–102
  195. Respondek M, Kammermeier M, Ludomirsky A, et al. The prevalence and clinical significance of fetal tricuspid valve regurgitation with normal heart anatomy. Am J Obstet Gynecol. 1994;171:1265–1270
  196. Huhta JC. Future directions in noninvasive Doppler evaluation of the fetal circulation. Cardiol Clin. 1989;7:239–253
  197. Tulzer G, Gudmundsson S, Sharkey AM, et al. Doppler echocardiography of fetal ductus arteriosus constriction versus increased right ventricular output. J Am Coll Cardiol. 1991;18:532–536
  198. Sklansky MS, DeVore GR, Wong PC. Real-time 3-dimensional fetal echocardiography with an instantaneous volume-rendered display (Early description and pictorial essay). J Ultrasound Med. 2004;23:283–289
  199. Sklansky MS, Nelson TR, Pretorius DH. Usefulness of gated three-dimensional fetal echocardiography to reconstruct and display structures not visualized with two-dimensional imaging. Am J Cardiol. 1997;80:665–668
  200. Sklansky MS, Nelson T, Strachan M, et al. Real-time three-dimensional fetal echocardiography: initial feasibility study. J Ultrasound Med. 1999;18:745–752
  201. Schindera ST, Mehwald PS, Sahn DJ, et al. Accuracy of real-time three-dimensional echocardiography for quantifying right ventricular volume. J Ultrasound Med. 2002;21:1069–1975
  202. Meyer-Wittkopf M, Cole A, Cooper SG, et al. Three-dimensional quantitative echocardiographic assessment of ventricular volume in healthy human fetuses and in fetuses with congenital heart disease. J Ultrasound Med. 2001;20:317–327
  203. Goncalves LF, Romero R, Espinoza J, et al. Four-dimensional ultrasonography of the fetal heart using color Doppler spatiotemporal image correlation. J Ultrasound Med. 2004;23:473–481
  204. Deng J, Sullivan ID, Yates R, et al. Real-time three-dimensional fetal echocardiography: optimal imaging windows. Ultrasound Med Biol. 2002;28:1099–1105
  205. DeVore GR, Falkensammer P, Sklansky MS, et al. Spatio-temporal image correlation (STIC): a new technology for evaluation of the fetal heart. Ultrasound Obstet Gynecol. 2003;22:380–387
  206. Michailidis GC, Simpson JM, Karidas C, et al. Detailed three-dimensional fetal echocardiography facilitated by an internet link. Ultrasound Obstet Gynecol. 2001;18:325–328
  207. Nelson TR, Pretorius DH, Sklansky M, et al. Three-dimensional echocardiographic evaluation of fetal heart anatomy and function: acquisition, analysis and display. J Ultrasound Med. 1996;15:1–9
  208. Rychik J, Ayres N, Cuneo B, et al. Pediatric Council of the American Society of Echocardiography American Society of Echocardiogrphy guidelines and standards for performance of the fetal echocardiogram. J Am Soc Echocardiogr. 2004;17:803–810
  209. Quinones MA, Douglas PS, Foster E, et al. ACC/AHA clinical competence statement on echocardiography (A report of the American College of Cardiology/American Heart Association/American College of Physicians—American Society of Internal Medicine task force on clinical competence). J Am Coll Cardiol. 2003;41:687–708
  210. Huhta JC. Right ventricular function in the human fetus. J Perinat Med. 2001;29:381–389
  211. Huhta JC. Guidelines for the evaluation of heart failure in the fetus with or without hydrops. Pediatr Cardiol. 2004;25:274–286
  212. Hecher K, Campbell S, Doyle P, et al. Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation. Circulation. 1995;91:129–138
  213. Harada K, Rice MJ, McDonald RW, et al. Doppler echocardiographic evaluation of ventricular diastolic filling in fetuses with ductal constriction. Am J Cardiol. 1997;79:442–446
  214. Kleinman CS, Nehgme RA. Cardiac arrhythmias in the human fetus. Pediatr Cardiol. 2004;25:234–251
  215. Respondek M, Wloch A, Kaczmarek P, et al. Diagnostic and perinatal management of fetal extrasystole. Pediatr Cardiol. 1997;18:361–366
  216. Hofbeck M, Ulmer H, Beinder E, et al. Prenatal findings in patients with prolonged QT interval in the neonatal period. Heart. 1997;77:198–204
  217. Buyon JP, Hiebert R, Copel JA, et al. Autoimmune-associated congenital heart block: mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol. 1998;31:1658–1666
  218. Nield LE, Silverman ED, Smallhorn JF, et al. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J Am Coll Cardiol. 2002;40:796–802
  219. Jaeggi ET, Fouron JC, Silverman ED, et al. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation. 2004;110:1542–1548
  220. Simpson LL, Marx GR, D’Alton ME. Supraventricular tachycardia in the fetus: conservative management in the absence of hemodynamic compromise. J Ultrasound Med. 1997;16:459–464
  221. Kleinman CS, Copel JA, Weinstein EM, et al. In utero diagnosis and treatment of fetal supraventricular tachycardia. Sem Perinatol. 1985;9:113–129
  222. Oudijk MA, Michon MM, Kleinman CS, et al. Sotalol in the treatment of fetal dysrhythmias. Circulation. 2000;101:2721–2726
  223. Rychik JF. Fetal cardiovascular physiology. Pediatr Cardiol. 2004;25:201–209
  224. Marshall AC, van der Velde ME, Tworetzky W, et al. Creation of an atrial septal defect in utero for fetuses with hypoplastic left heart syndrome and intact or highly restrictive atrial septum. Circulation. 2004;110:253–258

 The authors have no conflicts of interest to disclose.

PII: S0146-2806(07)00052-7

doi: 10.1016/j.cpcardiol.2007.04.004

Current Problems in Cardiology
Volume 32, Issue 8 , Pages 419-494 , August 2007